Issue Date | Title | Author(s) |
2021 | Risk of extrahepatic cancer in a nationwide cohort of hepatitis C virus infected persons treated with direct-acting antivirals | Charlotte, Lybeck |
2021 | Liver injury, SARS-COV-
2
infection and COVID-19:
What physicians should really know? | Anna, Licata |
2021 | Sodium-glucose
co-transporter
2 inhibitors reduce hepatic
events in diabetic patients with chronic hepatitis B | Lilian, Yan Liang |
2021 | Biliary stent placement without endoscopic sphincterotomy
in patients with common bile duct stones | Aye-Mya, Mya Kyaw |
2021 | A ‘real-world’
retrospective multi-centre
cohort study
comparing infliximab and adalimumab for the maintenance of
remission in ulcerative colitis
Victoria Tatiana Kronsten | Victoria, Tatiana Kronsten |
2021 | Cancer incidence and factors associated with malignancies in
coeliac disease during long-term
follow-up | Inka, Koskinen |
2021 | Helicobacter pylori eradication by low-dose
rifabutin triple
therapy (RHB-105)
is unaffected by high body mass index | John, Y. Kao |
2021 | Dried blood spot-based
detection of serological profiles of
hepatitis B and C infections and their prevalence in Cambodia | E, Bunthen |
2021 | Diagnostic accuracy of patient-reported
outcomes in predicting
endoscopic subscore in patients with ulcerative colitis | Jean-Frederic, Colombel |
2021 | Effect of cholecystectomy on bile acid diarrhoea biomarkers: A
prospective clinical study | Christian, Borup |
2021 | Levofloxacin-based
Helicobacter pylori eradication in chronic
dyspepsia | Wai, Phyo Aung |
2020 | Validation of MRI-VLFF for the non-invasive measurement of
steatosis in children | Miriam, B. Vos |
2020 | COVID -19 and the gastroenterologist | Chief GastroHep |
2020 | Impact of COVID-19 pandemic on surveillance of
hepatocellular carcinoma: A study in patients with chronic
hepatitis C after sustained virologic response | Hidenori, Toyoda |
2020 | The effects of COVID-19 on IBD prescribing and service
provision in a UK tertiary centre | Esha, Sharma |
2020 | A novel distinctive form of identification for differential
diagnosis of irritable bowel syndrome, inflammatory bowel
disease, and healthy controls | Sara, Ramió-Pujol |
2020 | Proton pump inhibitors are not associated with an increased
risk of colorectal cancer | Josephina G., Kuiper |
2020 | Rifamycin vs placebo for the treatment of acute uncomplicated
diverticulitis: A randomised, double-blind study | Wolfgang, Kruis |
2019 | External validation of an algorithm combining multi‐analyte
blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of
hepatocellular carcinoma in patients with chronic liver disease | Valentina, Peta |
2019 | Letter: lactic acidosis during anti-viral therapy in patients with
hepatitis B virus infection: A note of caution | Ramesh, Kumar |